USPTO 2015–2025 USPTO PatentsView US Corporation

Cour Pharmaceuticals Development Company Inc.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cour ranks #45,903 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#45,903
of 49,997 US assignees by volume
Top 40%
by Innovation Score (38.7/100)
18.8
avg claims per patent
-33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45903 · US Corporation #45,903 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,903/49,997
  • PHOTO-FINISH Cosmed S r l
  • CPC-NARROW A61K · 5 areas
  • INNOV-THIN 38.7/100
  • CLAIMS-RICH 18.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -33% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cosmed S.r.l. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cour’s 38.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cour

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cour's Innovation Score is 38.7/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cour?

Each dot is one of Cour’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cour’s own 18.8 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cour vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 4.95.05.055.05.05.1 510152025 Granted patents (volume) Avg claims / patent Cosmed S.r.l. - 5, 9.4Cosmed S r lCottonwood Creek Technologies, Inc. - 5, 16.6Cottonwood CreekCouncil OF Scientific AND Industrial Research AN Indian Registered Body Incorporated Under THE Regn. OF SOC. ACT (ACT XXI OF 1860) - 5, 7.6Council OF Scient…Country View Medical Center - 5, 21.4Country View Medi…Coventya GMBH - 5, 16CoventyaCOX Engineering Company - 5, 17.8COX EngineeringCOX Goettl Valve LLC - 5, 19.6COX Goettl ValveCPI Card GROUP—TENNESSEE, Inc. - 5, 23.4CPI Card Group—Te…Cour Pharmaceuticals Development Company Inc. - 5, 18.8Cour Pharmaceutic…
Cour vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cour's grants concentrate

Cour Pharmaceuticals Development Company Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2019. By volume, Cour sits between Cosmed S.r.l. and CPI Card GROUP—TENNESSEE, Inc..

Cour's three-year grant acceleration

Cour Pharmaceuticals Development Company Inc. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Cour's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cour holds 5 patents at rank #45,650, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cour

By rank, the assignees closest to #45,650 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Cour's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cour, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Cour ranks #4,009 of 7,163 assignees by patent count in that subclass.

Cour's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201820192022 2
USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Cour Pharmaceuticals Development Company Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 40.0%
2019 1 20.0%
2022 2 40.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cour Pharmaceuticals Development Company Inc.'s patent record in context - here's where to go next.

  • Cour Pharmaceuticals Development Company Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #45,903 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cour Pharmaceuticals Development Company Inc. against Cosmed S.r.l., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.